RE:RE:RE:RE:RE:RE:MondayAh, so we're back to this article! You realize that there's really no content in there, right? The most they increased is actually 100% for one drug in the US, and most drugs in England were increased 50%. That's really nothing that can explain a potential loss of 50M of revenue because a 100% increase is more than acceptable even in this environment.
Also, all of these regulations talk are nonsense. What are governments going to do, decide randomly of what is the maximum price of a drug for a specific treatment? How can this be enforced? It would kill R&D and development of future important medicine.
I've never been a pumper (I'm somewhat being caller a bashed on this forum for suggesting the share price might drop from time to time) but you have to realize CXR's price increases are a non story and just a short strategy to spread negativity, which seems to be failing from what I can see.
fdfd12 wrote: Concordia Healthcare has gone on a debt-fueled acquisition binge, including a deal for Donnatal, which has seen its price rise by 800% since 2010.